Corporate Governance20 Jul 2026, 11:00 pm
Gland Pharma Reappoints Mr. Vetter, Appoints Mr. Keller as Independent Directors
AI Summary
Gland Pharma Ltd announced the reappointment of Mr. Udo Jahannes Vetter and the appointment of Mr. William Robert Keller as Independent Directors. Mr. Vetter's second term as Independent Director will be for five years, effective July 21, 2026, to July 20, 2031. Mr. Keller has been appointed as an Independent Director for a five-year term, effective June 15, 2026, to June 14, 2031. Both appointments were approved by shareholders via postal ballot (e-voting), and remuneration in the form of commission on profits has also been approved for both directors. The company has filed the voting results and scrutinizer's report with the stock exchanges.
Key Highlights
- Mr. Udo Jahannes Vetter reappointed as Independent Director for a second five-year term.
- Mr. William Robert Keller appointed as Independent Director for a five-year term.
- Shareholders approved both appointments via postal ballot (e-voting).
- Remuneration for both directors approved as commission on profits.
- Effective dates for Mr. Vetter and Mr. Keller's terms are July 21, 2026, and June 15, 2026, respectively.
Price Impact
More from GLAND